JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
Opendoor
OPEN
$2.37B
| $4.08M | ﹤0.01% |
2,633,643
-507,481
| -16% | -$920K |
2021 Q2
14 quarters
|
|
3427
PJT Partners
PJT
$3.55B
| $4.08M | ﹤0.01% |
25,833
-46,437
| -64% | -$7.08M |
2015 Q4
36 quarters
|
|
3428
Dimensional National Municipal Bond ETF
DFNM
$2.23B
| $4.07M | ﹤0.01% |
85,235
-5,560
| -6% | -$268K |
2023 Q3
5 quarters
|
|
3429
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.62B
| $4.07M | ﹤0.01% |
36,131
+813
| +2% | +$95.5K |
2017 Q3
29 quarters
|
|
3430
Invesco Total Return Bond ETF
GTO
$2.43B
| $4.07M | ﹤0.01% |
87,734
-19,209
| -18% | -$905K |
2023 Q3
5 quarters
|
|
3431
PUT
Alaska Air
ALK
$4.41B
| $4.06M | ﹤0.01% |
62,700
+60,000
| +2,222% | +$3.15M |
2023 Q1
7 quarters
|
|
3432
Vanguard Russell 2000 Value ETF
VTWV
$1.32B
| $4.06M | ﹤0.01% |
28,061
-807
| -3% | -$121K |
2020 Q2
18 quarters
|
|
3433
PUT
Affirm
AFRM
$23.9B
| $4.06M | ﹤0.01% |
+66,600
| New | +$3.7M |
2024 Q4
0 quarters
|
|
|
SPTN
3434
DELISTED
SpartanNash
SPTN
| $4.05M | ﹤0.01% |
220,964
+118,478
| +116% | +$2.37M |
2013 Q2
46 quarters
|
|
3435
STAAR Surgical
STAA
$1.13B
| $4.05M | ﹤0.01% |
166,648
-48,102
| -22% | -$1.37M |
2017 Q4
28 quarters
|
|
3436
CALL
Ally Financial
ALLY
$11.5B
| $4.05M | ﹤0.01% |
112,400
-130,800
| -54% | -$4.75M |
2024 Q1
3 quarters
|
|
|
3437
PUT
Ally Financial
ALLY
$11.5B
| $4.05M | ﹤0.01% |
112,400
+23,900
| +27% | +$868K |
2024 Q1
3 quarters
|
|
3438
Ligand Pharmaceuticals
LGND
$6.04B
| $4.05M | ﹤0.01% |
37,761
-18,690
| -33% | -$2.11M |
2015 Q4
36 quarters
|
|
3439
PUT
eBay
EBAY
$47.3B
| $4.05M | ﹤0.01% |
65,300
-32,500
| -33% | -$2.06M |
2024 Q3
1 quarter
|
|
3440
CALL
Norfolk Southern
NSC
$71.3B
| $4.04M | ﹤0.01% |
17,200
+17,000
| +8,500% | +$4.32M |
2024 Q3
1 quarter
|
|
3441
Arbor Realty Trust
ABR
$664M
| $4.03M | ﹤0.01% |
291,107
-9,120
| -3% | -$134K |
2020 Q1
19 quarters
|
|
3442
CALL
Antero Resources
AR
$10.5B
| $4.03M | ﹤0.01% |
115,000
| – | – |
2023 Q4
4 quarters
|
|
3443
PUT
KeyCorp
KEY
$21.4B
| $4.03M | ﹤0.01% |
+235,000
| New | +$4.22M |
2024 Q4
0 quarters
|
|
3444
Burke & Herbert Financial Services Corp
BHRB
$1.41B
| $4.02M | ﹤0.01% |
64,526
+31,327
| +94% | +$2.05M |
2023 Q2
6 quarters
|
|
3445
Thryv Holdings
THRY
$67.5M
| $4.02M | ﹤0.01% |
271,874
+49,697
| +22% | +$783K |
2021 Q2
14 quarters
|
|
3446
Titan International
TWI
$451M
| $4.02M | ﹤0.01% |
592,087
-122,007
| -17% | -$879K |
2021 Q2
14 quarters
|
|
3447
Arcturus Therapeutics
ARCT
$370M
| $4.01M | ﹤0.01% |
236,368
-20,348
| -8% | -$383K |
2019 Q2
22 quarters
|
|
3448
Riot Platforms
RIOT
$7.4B
| $4.01M | ﹤0.01% |
392,863
-640,550
| -62% | -$6.98M |
2020 Q3
17 quarters
|
|
3449
FTAI Infrastructure
FIP
$318M
| $4.01M | ﹤0.01% |
552,459
+34,165
| +7% | +$293K |
2023 Q2
6 quarters
|
|
|
HPP
3450
Hudson Pacific Properties
HPP
$623M
| $4.01M | ﹤0.01% |
188,975
+136,056
| +257% | +$3.72M |
2014 Q4
40 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.